What is the rationale for multimodal analgesia in perioperative care?

• A. Reduces opioid requirements and side effects by using multiple mechanisms of action
• B. Prolongs analgesia by focusing on a single mechanism
• C. Relies solely on NSAIDs
• D. Eliminates need for nonopioids entirely

Answer: (A)

Using different pain pathways through multiple agents lets you achieve stronger overall pain relief with lower opioid doses. This additive or synergistic effect means you can control pain effectively while reducing opioids and their side effects, such as nausea, constipation, oversedation, and respiratory depression. In perioperative care, this approach combines nonopioid drugs (like acetaminophen and NSAIDs), regional or local techniques, and other adjuvants (like gabapentinoids or NMDA antagonists) to cover multiple mechanisms of pain transmission. The idea isn’t that one drug does all the work, but that several drugs together address different points in the pain pathway so you can spare opioids. The alternatives don’t fit because focusing on a single mechanism misses the benefit of synergistic analgesia; relying only on NSAIDs ignores other valuable nonopioid mechanisms and regional approaches; and it’s not realistic to eliminate nonopioids entirely since they’re central to achieving opioid-sparing effects.